Jim Hoffman: Targeting NETosis and Microclotting to Restore Immune and Hemostatic Balance
Jim Hoffman, Former Technical Advisor at Cygnus Technologies, LLC, shared Ronald Li’s post on LinkedIn, adding:
“Very interesting and informative in vitro studies.
You may want to investigate this further with Resia Pretorius and the PolyBio team who are looking for better treatment of microclotting, post infection Illnesses, including Long COVID PASC.
Perhaps desulfated-heparin analogs could help better mitigate the development of severe life-threatening NETosis dysregulation and circulatory decline, if tried in vivo.
However, I still prefer trying NETs/extracellular chromatin/histone removal from the blood using these emerging extracorporeal blood purification treatments for patients at high-risk of refractory SIRS and development of life-threatening sepsis/DIC.
Based on the largely failed clinical performance of systemically administered Activated Protein C, I have long believed the depletion of circulating charged histones and other extracellular chromatin debris that aggregates cells, rather than drug neutralization of histones, provides the greatest opportunity for restoring immune system homeostasis and improving blood hemostasis in response to infection and other triggers of worsening NETosis dysregulation.”
Ronald Li, Associate Professor in Emergency and Critical Care at North Carolina State University, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Frontiers in Veterinary Science:
“Congratulations Dr. Maria Andrea Guzman Solano on this publication.
As a member of the graduating class of the Veterinary Academic Leadership Fellow program at NC State College of Veterinary Medicine, she successfully advanced her research idea from conception through execution to publication.
I am excited to see her continue this research path as she takes on a new role as Associate Professor of Emergency and Critical Care at the University of Missouri.”
Title: Non-anticoagulant heparin attenuates histone-mediated platelet–leukocyte aggregation and neutrophil extracellular trap formation in a canine whole blood model
Authors: Maria A. Guzmán, Lunden Simpson, Ronald H. L. Li
Other posts featuring Jim Hoffman on Hemostasis Today.
-
Jul 23, 2026, 20:46Grace Choung: A Novel CFHR5 Copy Number Variant in Postpartum Atypical HUS
-
Jul 23, 2026, 20:10Mohammad Alzoubi: One Month of Dual Antithrombotic Therapy After PCI Was Non-Inferior to 12 Months
-
Jul 23, 2026, 20:08Ahmed Bennis: Calcitriol Replenishment May Mitigate Ischemic Risk in MASLD
-
Jul 23, 2026, 20:06Mitsuaki Sawano: Can Cardiovascular Risk Prediction Models Developed in One Population be Reliably Applied to Another?
-
Jul 23, 2026, 20:05Abdul Muqtadir Abbasi: Hemostasis Isn’t About Memorizing Factor Numbers – It’s About Recognizing Patterns
-
Jul 23, 2026, 19:40Maureen Macharia: How Apixaban Transformed Modern Anticoagulation
-
Jul 23, 2026, 19:30Jordan Agay: Why We Need to Track the Neurological Costs of Anemia
-
Jul 23, 2026, 19:25William Archibald: Key Takeaways on VTE Cost-Effectiveness and Cancer Associated Thrombosis from ISTH 2026
-
Jul 23, 2026, 19:17Diego López Santos: Donation after Donation, I Just Reached 100